SV

Street Verdict

Analyst Scorecard

A record of what Ganesh Dongre said publicly, with the source. Not advice.

“Bullish on Aurobindo Pharma Ltd, recommending a buy at ₹1,135 with a stop loss at ₹1,110 for a target price of ₹1,170. A bullish reversal pattern has emerged in the short-term trend, suggesting a potential retracement to the target, with the stock maintaining a crucial support level.”

Ganesh Dongre’s track record (trackable calls only): 327 graded calls · 95% CI 33–44%

Aurobindo Pharma LtdBullishCalled 20 Feb 2025Graded 24 Feb 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,135, as stated.

Target ₹1,170, stop ₹1,110, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,170 or ₹1,110: there is no fixed window.

The stop ₹1,110 was reached on a close before the target ₹1,170. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1135 on 2025-02-21 (stated entry ₹1135, LEVEL_CMP entry, filled); stop ₹1110 breached at close ₹1101.8 on 2025-02-24. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Aurobindo Pharma Ltd since this call

1-year tracking window
Read the original articleSee Ganesh Dongre’s full track record